Literature DB >> 8032640

Attenuation by chlormethiazole administration of the rise in extracellular amino acids following focal ischaemia in the cerebral cortex of the rat.

H A Baldwin1, J L Williams, M Snares, T Ferreira, A J Cross, A R Green.   

Abstract

1. In vivo microdialysis has been used to investigate the concentration of various amino acids and lactate in the extracellular fluid of the rat cortex following focal ischaemia, the probe being placed in the core of the infarct area. 2. An ischaemic infarct was produced in the cortex by use of a photochemical dye (Rose Bengal) and light irradiation. There was a marked increase in lactate concentration (300%) over the next 4 h. Substantial increases were also seen in the concentration of the excitatory (glutamate and aspartate), inhibitory (GABA and taurine) and other amino acids (serine, alanine, asparagine). 3. Administration of chlormethiazole (200 mg kg-1, i.p.) 5 min after the onset of ischaemia reduced the ischaemia-induced neurodegeneration by approximately 30%, measured histologically 24 h later. 4. Chlormethiazole (200 mg kg-1, i.p.) administration also reduced the rise in the concentration of lactate and all the amino acids by between 30-60% during the first 4 h after the onset of ischaemia. 5. Analysis of the time course of the amino acid changes suggested that chlormethiazole is not neuroprotective because of the inhibition of excitatory amino acid release but rather that the attenuated rise in the concentration of all the amino acids is reflective of neuroprotection and therefore decreased cell death. 6. This conclusion was supported by the observation that the enhanced efflux of glutamate from slices of cerebral cortex which had been induced by incubation of the slices in an hypoxic medium was unaltered by the presence of a high concentration of chlormethiazole (1 mM) in the medium. 7. Overall the data strengthen the evidence for the neuroprotective effect of chlormethiazole in this model of focal ischaemia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8032640      PMCID: PMC1910275          DOI: 10.1111/j.1476-5381.1994.tb13050.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis.

Authors:  M Y Globus; R Busto; W D Dietrich; E Martinez; I Valdes; M D Ginsberg
Journal:  J Neurochem       Date:  1988-11       Impact factor: 5.372

2.  Extracellular lactic acid as an indicator of brain metabolism: continuous on-line measurement in conscious, freely moving rats with intrastriatal dialysis.

Authors:  W G Kuhr; J Korf
Journal:  J Cereb Blood Flow Metab       Date:  1988-02       Impact factor: 6.200

3.  Quantitation of photochemically induced focal cerebral ischemia in the rat.

Authors:  J J Grome; G Gojowczyk; W Hofmann; D I Graham
Journal:  J Cereb Blood Flow Metab       Date:  1988-02       Impact factor: 6.200

4.  MK-801 is neuroprotective in gerbils when administered during the post-ischaemic period.

Authors:  R Gill; A C Foster; G N Woodruff
Journal:  Neuroscience       Date:  1988-06       Impact factor: 3.590

5.  2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.

Authors:  M J Sheardown; E O Nielsen; A J Hansen; P Jacobsen; T Honoré
Journal:  Science       Date:  1990-02-02       Impact factor: 47.728

6.  The effects of chlormethiazole and nimodipine on cortical infarct area after focal cerebral ischaemia in the rat.

Authors:  M F Snape; H A Baldwin; A J Cross; A R Green
Journal:  Neuroscience       Date:  1993-04       Impact factor: 3.590

7.  Taurine improves the recovery of neuronal function following cerebral hypoxia: an in vitro study.

Authors:  A Schurr; M T Tseng; C A West; B M Rigor
Journal:  Life Sci       Date:  1987-05-25       Impact factor: 5.037

8.  The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat.

Authors:  C K Park; D G Nehls; D I Graham; G M Teasdale; J McCulloch
Journal:  Ann Neurol       Date:  1988-10       Impact factor: 10.422

9.  Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists.

Authors:  D W Choi; J Y Koh; S Peters
Journal:  J Neurosci       Date:  1988-01       Impact factor: 6.167

10.  Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats.

Authors:  M De Ryck; J Van Reempts; M Borgers; A Wauquier; P A Janssen
Journal:  Stroke       Date:  1989-10       Impact factor: 7.914

View more
  17 in total

1.  Neuroprotective effects by nimodipine treatment in the experimental global ischemic rat model : real time estimation of glutamate.

Authors:  Seok Keun Choi; Gi-Ja Lee; Samjin Choi; Youn Jung Kim; Hun-Kuk Park; Bong Jin Park
Journal:  J Korean Neurosurg Soc       Date:  2011-01-31

2.  Novel analogues of chlormethiazole are neuroprotective in four cellular models of neurodegeneration by a mechanism with variable dependence on GABA(A) receptor potentiation.

Authors:  Lawren Vandevrede; Ehsan Tavassoli; Jia Luo; Zhihui Qin; Lan Yue; David R Pepperberg; Gregory R Thatcher
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

3.  Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain.

Authors:  María Izco; Laura Orio; Esther O'Shea; M Isabel Colado
Journal:  Psychopharmacology (Berl)       Date:  2006-10-18       Impact factor: 4.530

4.  A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain.

Authors:  M I Colado; J Camarero; A O Mechan; V Sanchez; B Esteban; J M Elliott; A R Green
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

5.  A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice.

Authors:  Isabel Escobedo; Esther O'Shea; Laura Orio; Veronica Sanchez; Mireia Segura; Rafael de la Torre; Magi Farre; Alfred Richard Green; Maria Isabel Colado
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

6.  Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration.

Authors:  M I Colado; E O'Shea; R Granados; B Esteban; A B Martín; A R Green
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

7.  The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.

Authors:  Annis O Mechan; Blanca Esteban; Esther O'Shea; J Martin Elliott; M Isabel Colado; A Richard Green
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

8.  The protective action of chlormethiazole against ischaemia-induced neurodegeneration in gerbils when infused at doses having little sedative or anticonvulsant activity.

Authors:  A J Cross; J A Jones; M Snares; K G Jostell; U Bredberg; A R Green
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

9.  The effect of chlormethiazole on neuronal damage in a model of transient focal ischaemia.

Authors:  S G Sydserff; A J Cross; K J West; A R Green
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

10.  A microdialysis study of glycinamide, glycine and other amino acid neurotransmitters in rat frontal cortex and hippocampus after the administration of milacemide, a glycine pro-drug.

Authors:  M H Doheny; S Nagaki; P N Patsalos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-07       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.